Claude and Claude Code

Start with the Consequence

A founder is deciding what to delegate to AI and what evidence to require before accepting the result.

The immediate question is claude and claude code. The technical label matters only because it changes a product decision, a responsibility, or the evidence required before launch.

Turn the Term into Evidence

Start with the product consequence, then choose the simplest technical treatment that protects it. A longer tool list is not a stronger plan.

For this decision, the useful standard is that the output satisfies explicit constraints and survives review outside the conversation that produced it.

• Make the decision explicit: Evaluate the tool by repository fit, permissions, review controls, team workflow, and quality of verification rather than brand preference.
• Ask what evidence would show that the chosen approach works.
• Name the person or provider responsible when the approach fails.
• Record the result in the AI work brief, review record, and acceptance criteria.

Match the Control to the Consequence

Evaluate the tool by repository fit, permissions, review controls, team workflow, and quality of verification rather than brand preference.

The principal risk is that broad agent access is granted without a clear task boundary or review of the resulting changes. This does not require the most expensive possible solution. It requires the consequence to be understood and the control to match it.

1. Describe the user or business outcome that must be protected.
2. Identify the most credible failure and its consequence.
3. Compare the simplest adequate approach with one realistic alternative.
4. Set a review point for when the decision may need to change.

Evidence Compared with Assumption

Warning Signs

• Nobody can explain how claude and claude code changes a user or business outcome.
• The proposal does not address this risk: broad agent access is granted without a clear task boundary or review of the resulting changes.
• The only evidence is a successful demonstration of the easiest path.
• The decision has no named owner, boundary, or review point.
• A provider-specific feature is being mistaken for a permanent product requirement.

Questions to Ask a Consultant

• What decision are we making about claude and claude code?
• Which user or business outcome does the recommendation protect?
• How have we reduced or accepted this risk: broad agent access is granted without a clear task boundary or review of the resulting changes.
• What evidence can I review without relying on the original implementer?
• What is deliberately deferred, and when will it be reconsidered?
• Who owns the accounts, data, documentation, and recovery process?